Company
Merus
Merus has 7 drugs tracked on RxWires: 1 in Phase 3, 2 in Phase 2, 2 in Phase 1/2, 2 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Petosemtamab | Phase 3 | Head and Neck Squamous Cell Carcinoma |
| Zenocutuzumab | Phase 2 | Breast Cancer Metastatic |
| Petosemtamab + Pembrolizumab | Phase 2 | Lung Cancer - Non Small Cell Squamous |
| MCLA-158 | Phase 1/2 | Advanced/Metastatic Solid Tumors |
| MCLA-129 | Phase 1/2 | Non-Small Cell Lung Cancer Metastatic |
| MCLA-117 bispecific antibody | Phase 1 | Acute Myelogenous Leukemia |
| MCLA-145 | Phase 1 | Advanced Cancer |
Latest
No recent events.
Follow Merus on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.